Canine aging research is advancing rapidly, with studies examining the biology of dog aging, interventions that may extend healthy lifespan, and the welfare implications of aging-related disease prevention.
Canine aging research with welfare implications focuses not on extending life at any cost but on extending the period during which dogs experience good health, mobility, and quality of life. The distinction between lifespan and healthspan is welfare-critical: additional years of life spent in chronic pain, cognitive decline, or organ failure without adequate management represent welfare harm rather than welfare benefit. Interventions that compress the period of age-related decline — allowing dogs to remain healthy and functional longer before rapid end-of-life decline — represent the highest-value welfare outcome of aging research. Owner engagement with proactive senior wellness monitoring, appropriate nutrition for aging stages, and timely end-of-life decision-making when quality of life deteriorates substantially defines the welfare standard for aging dogs. Research that identifies biomarkers of accelerated aging enables earlier intervention before irreversible decline.